Cutaneous allodynia as a predictor of migraine chronification

Brain

Volumn 136, Issue 11, 2013, Pages 3489-3496

  Louter, Mark A ^a   Bosker, Johanneke E ^a   Van Oosterhout, Willebrordus P J ^a   Van Zwet, Erik W ^a   Zitman, Frans G ^a   Ferrari, Michel D ^a   Terwindt, Gisela M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic migraine; Cutaneous allodynia; Depression; Medication overuse; Migraine

Indexed keywords

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL FEATURE; CUTANEOUS ALLODYNIA; DEMOGRAPHY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITHOUT AURA; MORBIDITY; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE;

EID: 84890531215     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt251     Document Type: Article

References (29)

1. Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, et al. Depression and risk of transformation of episodic to chronic migraine. J Headache Pain 2012; 13: 615-24.
2. Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol 2012; 8: 89-99.
3. Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008; 70: 1525-33.
4. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache 2006; 46: 1334-43.
5. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
6. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55: 19-26.
7. Burstein R, Jakubowski M, Rauch SD. The science of migraine. J Vestib Res 2011; 21: 305-14.
8. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000; 47: 614-24.
9. De Felice M, Ossipov MH, Wang R, Dussor G, Lai J, Meng ID, et al. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain 2010; 133: 2475-88.
10. Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence? Pain 2005; 119: 49-55.
11. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 (Suppl 1): 9-160.
12. Kalita J, Yadav RK, Misra UK. A comparison of migraine patients with and without allodynic symptoms. Clin J Pain 2009; 25: 696-8.
13. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999; 53: 537-42.
14. Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008; 63: 148-58.
15. Lipton RB, Penzien DB, Turner DP, Smitherman TA, Houle TT. Methodological issues in studying rates and predictors of migraine progression and remission. Headache 2013; 53: 930-4.
16. Lovati C, D'Amico D, Bertora P. Allodynia in migraine: frequent random association or unavoidable consequence? Expert Rev Neurother 2009; 9: 395-408.
17. Lovati C, D'Amico D, Rosa S, Suardelli M, Mailland E, Bertora P, et al. Allodynia in different forms of migraine. Neurol Sci 2007; 28 (Suppl 2): S220-1.
18. Mathew NT, Kailasam J, Seifert T. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848-52.
19. Mercante JP, Peres MF, Guendler V, Zukerman E, Bernik MA. Depression in chronic migraine: severity and clinical features. Arq Neuropsiquiatr 2005; 63: 217-20.
20. Radat F, Sakh D, Lutz G, el Amrani M, Ferreri M, Bousser MG. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 1999; 39: 477-80.
21. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
22. Rome HP Jr, Rome JD. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med 2000; 1: 7-23.
23. Schur EA, Noonan C, Buchwald D, Goldberg J, Afari N. A twin study of depression and migraine: evidence for a shared genetic vulnerability. Headache 2009; 49: 1493-502.
24. Stam AH, de Vries B, Janssens AC, Vanmolkot KRJ, Aulchenko YS, Henneman P, et al. Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology 2010; 74: 288-94.
25. Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, et al. Allodynia in migraine: association with comorbid pain conditions. Headache 2009; 49: 1333-44.
26. van Oosterhout WP, Weller CM, Stam AH, Bakels F, Stijnen T, Ferrari MD, et al. Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineurs. Cephalalgia 2011; 31: 1359-67.
27. Vieira DS, Naffah-Mazacoratti MG, Zukerman E, Senne Soares CA, Alonso EO, Faulhaber MH, et al. Cerebrospinal fluid GABA levels in chronic migraine with and without depression. Brain Res 2006; 1090: 197-201.
28. World Health Organisation. Composite International Diagnostic Interview -Version 2.1. Geneva: World Health Organisation; 1997.
29. Young WB, Richardson ES, Shukla P. Brush allodynia in hospitalized headache patients. Headache 2005; 45: 999-1003.